References
Goldsmith DJ, Gusbeth-Tatomir P, Covic A (2007) Vascular calcification––a new window on the cardiovascular system: role of agents used to manipulate skeletal integrity. Semin Dial 20(2):158–169. doi:10.1111/j.1525-139X.2007.00254.x
Goldsmith D, Ritz E, Covic A (2004) Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? Kidney Int 66:1315–1333. doi:10.1111/j.1523-1755.2004.00895.x
Braun J, Oldendorf M, Moshage W et al (1996) Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394–401. doi:10.1016/S0272-6386(96)90363-7
Russo D, Miranda I, Ruocco C (2007) The progression of coronary artery calcification in predialysis patients on sevelamer or calcium carbonate. Kidney Int 72(10):1255–1261. doi:10.1038/sj.ki.5002518
Chertow GM, Burke SK, Raggi P (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245–252. doi:10.1046/j.1523-1755.2002.00434.x
Block GA, Spiegel DM, Ehrlich J et al (2005) Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68:1815–1824. doi:10.1111/j.1523-1755.2005.00600.x
Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM (2007) Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 71:438–441. doi:10.1038/sj.ki.5002059
Nikolov IG, Joki N, Maizel J et al (2006) Pleiotropic effects of the non-calcium phosphate binder sevelamer. Kidney Int 70:S16–S23. doi:10.1038/sj.ki.5001994
Qunibi WY, Moustafa M, Muenz LR et al (2008) A 1 year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2). Am J Kidney Dis 51(6):952–965
Qunibi WY, Hootkins RE, McDowell LL et al (2004) Treatment of hyperphosphatemia in hemodialysis patients: the Calcium Acetate Renagel Evaluation (CARE Study). Kidney Int 65(5):1914–1926. doi:10.1111/j.1523-1755.2004.00590.x
Wanner C, Krane V, März W et al (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353:238–248. doi:10.1056/NEJMoa043545
Kestenbaum B (2008) Calcification in CKD. No closer to the cure. Am J Kidney Dis 51(6):877–879
Cademartiri F (2006) Is calcium the key for the assessment of progression/regression of coronary artery disease? Heart 92:1187–1188. doi:10.1136/hrt.2006.089573
Ferreira A, Frazao JM, Monier-Faugere MC et al (2008) Effects of sevelamer and calcium carbonate on renal osteodystrophy in haemodialysis patients. J Am Soc Nephrol 19(2):405–412. doi:10.1681/ASN.2006101089
London GM, Marty C, Marchais SJ et al (2004) Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15:1943–1951. doi:10.1097/01.ASN.0000129337.50739.48
London GM, Marchais SV, Guerin AP et al (2008) Association of bone activity, calcium load, aortic stiffness and calcifications in ESRD. J Am Soc Nephrol 19:1827–1835. doi:10.1681/ASN.2007050622
Moe S, Drüeke T, Cunningham J et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945–1953. doi:10.1038/sj.ki.5000414
Covic A, Gusbeth-Tatomir P, Goldsmith DJA (2008) Negative outcome studies in end-stage renal disease––how dark are the storm clouds. Nephrol Dial Transplant 23(1):56–61. doi:10.1093/ndt/gfm706
Yuen D, Pierratos A, Richardson RM, Chan CT (2006) The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplant 21:1407–1412. doi:10.1093/ndt/gfl021
Demer LL, Tintut Y (2008) Vascular calcification: pathobiology of a multi-faceted disease. Circulation 117:2938–2948. doi:10.1161/CIRCULATIONAHA.107.743161
Spasovski GB (2007) Bone health and vascular calcification relationships in chronic kidney disease. Int Urol Nephrol 39:1209–1216
Kovesdy CP, Kalantar-Zadeh K (2008) Bone and mineral disorders in pre-dialysis CKD. Int Urol Nephrol 40:427–440
Acknowledgements
Dr Goldsmith has received speaker/advisory fees from Genzyme, Shire, Fresenius, Roche, Amgen, and Abbott. Professor Covic has received speaker/advisory fees from Amgen, Fresenius, and Roche.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goldsmith, D.J.A., Covic, A. Calcium and the saga of the binders: accumulating controversy, or building consensus?. Int Urol Nephrol 40, 1009–1014 (2008). https://doi.org/10.1007/s11255-008-9477-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-008-9477-x